Featured 13F manager
Third Point LLC Dan Loeb
New York, NY 20 processed 13Fs on this site · 2021 Q3–2026 Q2
- $4.7B
- 37 Positions
- 2026 Q2
- +124.7% QoQ
- Top 5 38.1%
Portfolio
top 5 38.1% · top 10 60.1%
- WBD - Warner Bros Discovery 11.4%
- AMZN - Amazon 8.9%
- GOOGL - Alphabet · CL A 7.8%
- CRH - CRH PLC 5.0%
- TDS - Telephone & Data Sys 5.0%
- TSM - Taiwan Semiconductor 4.7%
- LYV - Live Nation 4.4%
- KEYS - Keysight Technologies 4.4%
- SGI - Somnigroup International 4.3%
- XYZ - Block · CL A 4.2%
- NSC - Norfolk Southn 4.0%
- FLEX - Flextronics 3.6%
- Other 32.3%
AUM over time
Book
| PCG - Pg And E | 16.10% | Reduce −6.8% | 59,070,000 | $16.26 | $960M | −4,330,000 | +$168M |
| CL - Colgate Palmolive | 15.25% | Hold | 11,550,000 | $78.79 | $910M | — | — |
| DHR - Danaher | 12.01% | Hold | 2,700,000 | $265.42 | $717M | — | — |
| BBWI - Bath & Body Works | 9.71% | Add +69.0% | 13,750,000 | $42.14 | $579M | +5,615,000 | +$314M |
| UNH - Unitedhealth Group | 5.95% | Hold | 670,000 | $530.18 | $355M | — | — |
| AIG - American Intl Group | 5.40% | New | 5,100,000 | $63.24 | $323M | +5,100,000 | +$323M |
| MSFT - Microsoft | 4.74% | New | 1,180,000 | $239.82 | $283M | +1,180,000 | +$283M |
| IFF - International Flavors & Fragrances | 4.04% | New | 2,300,000 | $104.84 | $241M | +2,300,000 | +$241M |
| S - Sentinelone · CL A | 3.59% | Reduce −22.6% | 14,700,000 | $14.59 | $214M | −4,300,000 | −$271M |
| TJX - Tjx Cos | 3.53% | Add +51.4% | 2,650,000 | $79.60 | $211M | +900,000 | +$102M |
| DWDPEUR — | 3.45% | Add +26.3% | 3,000,000 | $68.63 | $206M | +625,000 | +$86M |
| OVV - Ovintiv | 3.40% | Hold | 4,000,000 | $50.71 | $203M | — | — |
| FIS - Fidelity Natl Info | 2.27% | New | 2,000,000 | $67.85 | $136M | +2,000,000 | +$136M |
| FERG - Ferguson | 1.97% | Hold | 925,000 | $126.97 | $117M | — | — |
| DIS - Disney Walt | 1.38% | Reduce −32.1% | 950,000 | $86.88 | $83M | −450,000 | −$50M |
| HTZ - Hertz Global | 1.38% | Hold | 5,350,000 | $15.39 | $82M | — | — |
| PCG - Pg And E | 1.14% | Hold | 471,000 | $144.24 | $68M | — | — |
| Laboratory Amer | 0.76% | New | 192,125 | $235.48 | $45M | +192,125 | +$45M |
| Holding · CL A | 0.68% | Hold | 4,000,000 | $10.10 | $40M | — | — |
| Holding | 0.66% | Hold | 8,537,601 | $4.63 | $40M | — | — |
| Ventyx Biosciences | 0.55% | Reduce −76.8% | 1,000,000 | $32.79 | $33M | −3,312,834 | −$118M |
| Holding · CL A | 0.33% | Hold | 2,000,000 | $9.96 | $20M | — | — |
| Blue Whale Acquisition · CLASS A | 0.33% | Hold | 2,000,000 | $9.79 | $20M | — | — |
| Rice Acquisition Ii · CL A | 0.26% | Hold | 1,500,000 | $10.17 | $15M | — | — |
| Holding · CL A | 0.20% | Hold | 1,200,000 | $9.86 | $12M | — | — |
| Eg Acquisition · CL A | 0.18% | Hold | 1,102,500 | $9.97 | $11M | — | — |
| Disruptive Acquisition | 0.17% | Hold | 1,000,000 | $10.06 | $10M | — | — |
| Holding · CLASS A | 0.17% | Hold | 1,000,000 | $9.95 | $10M | — | — |
| Holding · CLASS A | 0.17% | Hold | 992,739 | $9.97 | $10M | — | — |
| Ishares Tr | 0.08% | Add +0.7% | 60,758 | $81.17 | $5M | +412 | +$31K |
| AUR - Aurora Innovation · CLASS A | 0.02% | Hold | 1,032,463 | $1.21 | $1M | — | — |
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2022 Q3
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| 4.36% | Exit | 0 | $43.84 | $241M | −5,500,000 | −$241M | |
| EQT - EQT Corp | 2.39% | Exit | 0 | $40.75 | $132M | −3,250,000 | −$132M |
| RRC - Range Res | 1.78% | Exit | 0 | $25.26 | $99M | −3,900,000 | −$99M |
| TMUS - T-Mobile US | 1.70% | Exit | 0 | $134.17 | $94M | −700,000 | −$94M |
| Cano Health · CL A | 1.70% | Exit | 0 | $8.67 | $94M | −10,825,000 | −$94M |
| CSX - CSX Corp | 1.32% | Exit | 0 | $26.64 | $73M | −2,750,000 | −$73M |
| TTWO - Take Two | 0.98% | Exit | 0 | $109.00 | $54M | −500,000 | −$54M |
| CRK - Comstock Res | 0.94% | Exit | 0 | $17.29 | $52M | −3,000,000 | −$52M |
| Perimeter Solutions SA | 0.83% | Exit | 0 | $8.01 | $46M | −5,750,000 | −$46M |
| Avanti Acquisition · CL A | 0.54% | Exit | 0 | $10.02 | $30M | −3,000,000 | −$30M |
| Compute Health Acquisitin · CL A | 0.45% | Exit | 0 | $9.87 | $25M | −2,500,000 | −$25M |
| Ion Acquisition 3 · CL A | 0.32% | Exit | 0 | $9.87 | $18M | −1,800,000 | −$18M |
| Altimeter Growth 2 · CL A | 0.23% | Exit | 0 | $9.91 | $13M | −1,285,000 | −$13M |
| Lerer Hippeau Acquisition · CL A | 0.22% | Exit | 0 | $9.82 | $12M | −1,250,000 | −$12M |
| SEMA4 · CL A | 0.09% | Exit | 0 | $0.8775 | $5M | −5,545,000 | −$5M |
| AR - Antero Resources | 0.06% | Exit | 0 | $30.53 | $3M | −100,000 | −$3M |
| Relay Therapeutics | 0.04% | Exit | 0 | $22.37 | $2M | −100,000 | −$2M |
| Tpi Composites | 0.02% | Exit | 0 | $11.28 | $1M | −100,000 | −$1M |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 43 | $4.7B | +124.7% | 13F-HR | 8/14/2026 | 000104027326000003 |
| 2026 Q1 | 33 | $2.1B | −71.4% | 13F-HR | 5/15/2026 | 000104027326000002 |
| 2025 Q4 | 44 | $7.3B | −19.1% | 13F-HR | 2/17/2026 | 000104027326000001 |
| 2025 Q3 | 46 | $9B | +18.0% | 13F-HR | 11/14/2025 | 000104027325000003 |
| 2025 Q2 | 51 | $7.6B | +16.3% | 13F-HR | 8/14/2025 | 000108514625005277 |
| 2025 Q1 | 45 | $6.6B | −12.0% | 13F-HR | 5/15/2025 | 000108514625003337 |
| 2024 Q4 | 43 | $7.4B | +0.1% | 13F-HR | 2/14/2025 | 000108514625001713 |
| 2024 Q3 | 42 | $7.4B | −14.9% | 13F-HR | 11/14/2024 | 000108514624005927 |
| 2024 Q2 | 44 | $8.7B | +11.3% | 13F-HR | 8/14/2024 | 000108514624004004 |
| 2024 Q1 | 40 | $7.8B | +18.2% | 13F-HR | 5/15/2024 | 000108514624002645 |
| 2023 Q4 | 37 | $6.6B | +0.7% | 13F-HR | 2/14/2024 | 000108514624001503 |
| 2023 Q3 | 42 | $6.6B | −3.4% | 13F-HR | 11/14/2023 | 000108514623004511 |
| 2023 Q2 | 45 | $6.8B | +11.7% | 13F-HR | 8/14/2023 | 000108514623003432 |
| 2023 Q1 | 46 | $6.1B | +2.4% | 13F-HR | 5/15/2023 | 000108514623002451 |
| 2022 Q4 | 44 | $6B | +7.8% | 13F-HR | 2/14/2023 | 000108514623001325 |
| 2022 Q3 | 61 | $5.5B | +31.0% | 13F-HR | 11/14/2022 | 000108514622004128 |
| 2022 Q2 | 58 | $4.2B | −45.0% | 13F-HR | 8/15/2022 | 000108514622003130 |
| 2022 Q1 | 75 | $7.7B | −46.4% | 13F-HR | 5/16/2022 | 000108514622002202 |
| 2021 Q4 | 92 | $14.3B | −21.8% | 13F-HR | 2/14/2022 | 000108514622001108 |
| 2021 Q3 | 113 | $18.3B | — | 13F-HR | 11/15/2021 | 000108514621003377 |
About
Third Point LLC
20 processed 13Fs on this site · 2021 Q3–2026 Q2